In general, there is a controversy surrounding the role of SphK2 in cancer pathogenesis and treatment response with some studies showing pro-apoptotic and anti-tumorigenic functions of SphK2 and others indicating a pro-survival and oncogenic role. The gene discussed is SPHK2; the disease is cancer.